John E. Levine, MD

NPI 1720098353ActiveIndividual· Pediatrics, Pediatric Hematology-Oncology· New York, NY

Pediatrics, Pediatric Hematology-Oncology (MD) in New York, New York, trained at Eastern Virginia Medical School (class of 1989). Their prescriptions cost Medicare Part D more than their services did: $96,009 for 62 claims, against $14,123 paid for services in 2024. Mesoblast, Inc. was the largest of 7 companies reporting payments in 2025, $31,766 in all, mostly consulting fees.

Overview

NPI	1720098353
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Aug 8, 2006
Last updated in NPPES	Feb 26, 2019

Specialties and licenses

Taxonomy	Code	License	State
Pediatrics, Pediatric Hematology-Oncology Primary	2080P0207X	189751	NY
Internal Medicine, Medical Oncology	207RX0202X	189751	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematopoietic Cell Transplantation and Cellular Therapy (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	24
Services billed	142 across 8 procedure codes
Paid by Medicare	$14,123

Part D prescriptions in 2024

Prescriptions (claims)	62 · 74 30-day fills
Total drug cost	$96,009
Generic share	79% of claims

Medicare sources and data years

Education and affiliations

Medical school	Eastern Virginia Medical School
Graduation year	1989
Medicare specialty	Hematopoietic Cell Transplantation And Cellular Therapy
Secondary specialties	Medical Oncology, Pediatric Medicine